NanoRepro AG
XETRA:NN6

Watchlist Manager
NanoRepro AG Logo
NanoRepro AG
XETRA:NN6
Watchlist
Price: 1.485 EUR 1.02% Market Closed
Market Cap: €19.2m

NanoRepro AG
Investor Relations

NanoRepro AG engages in the development, manufacture, and distribution of diagnostic tests and food supplements for home and professional use. The company is headquartered in Marburg An Der Lahn, Hessen and currently employs 17 full-time employees. The company went IPO on 2012-10-09. The firm is engaged in the research of stem cells, which are used in the medical treatment due to their ability to self-renew and differentiate to a range of specialized cell types. Nanorepro AG gathers samples of patients’ stem cells and stores them for the future use. Its portfolio also comprises OTC rapid diagnostic tests, such as OvuQUICK, an ovulation test for women; GraviQUICK, a pregnancy test; MenoQUICK, a menopause test; VagiQUICK, a vaginal yeast test; GlutenCHECK, a test to detect celiac disease; CholesterinCHECK, a test to measure the level of total cholesterol, HDL and LDL, as well as FertiQUICK, a fertility test for men.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Ms. Lisa Jungst
President of the Management Board & CEO
No Bio Available
Mr. Stefan Pieh
CFO & Member of Management Board
No Bio Available

Contacts

Address
HESSEN
Marburg an der Lahn
Untergasse 8
Contacts
+496421951449.0
nanorepro.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett